LRMR logo

LRMR
Larimar Therapeutics Inc

4,957
Mkt Cap
$528.76M
Volume
1.9M
52W High
$6.42
52W Low
$1.73
PE Ratio
-2.20
LRMR Fundamentals
Price
$4.85
Prev Close
$5.09
Open
$5.11
50D MA
$4.34
Beta
1.60
Avg. Volume
2.31M
EPS (Annual)
-$2.26
P/B
5.18
Rev/Employee
$0.00
$146.10
Loading...
Loading...
News
all
press releases
Q1 Earnings Estimate for LRMR Issued By Lifesci Capital
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) - Investment analysts at Lifesci Capital issued their Q1 2026 EPS estimates for Larimar Therapeutics in a report issued on Wednesday, April 1st...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) have received an average recommendation of "Buy" from the ten brokerages that are presently covering the stock, MarketBeat.com...
MarketBeat·9d ago
News Placeholder
Larimar Therapeutics (LRMR) Expected to Announce Earnings on Monday
Larimar Therapeutics (NASDAQ:LRMR) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-larimar-therapeutics-inc-stock...
MarketBeat·19d ago
News Placeholder
Larimar Therapeutics (NASDAQ:LRMR) Stock Price Up 8.2% After Analyst Upgrade
Larimar Therapeutics (NASDAQ:LRMR) Stock Price Up 8.2% After Analyst Upgrade...
MarketBeat·22d ago
News Placeholder
Wedbush Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $13.00
Wedbush lifted their price target on shares of Larimar Therapeutics from $12.00 to $13.00 and gave the stock an "outperform" rating in a research note on Friday...
MarketBeat·22d ago
News Placeholder
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Sees Significant Decrease in Short Interest
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) saw a significant decline in short interest during the month of February. As of February 27th, there was short interest totaling 7,692,689...
MarketBeat·26d ago
News Placeholder
Mangrove Partners IM LLC Sells 327,997 Shares of Larimar Therapeutics, Inc. $LRMR
Mangrove Partners IM LLC decreased its position in Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) by 42.6% during the third quarter, according to its most recent disclosure with the...
MarketBeat·28d ago
News Placeholder
Investors Purchase Large Volume of Larimar Therapeutics Call Options (NASDAQ:LRMR)
Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) was the recipient of some unusual options trading activity on Friday. Traders acquired 3,011 call options on the stock. This is an increase...
MarketBeat·29d ago
News Placeholder
Larimar Therapeutics (NASDAQ:LRMR) Stock Price Down 8% - Should You Sell?
Larimar Therapeutics (NASDAQ:LRMR) Trading Down 8% - Here's Why...
MarketBeat·30d ago
News Placeholder
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
Larimar's stock jumps 55% in a month after the FDA grants breakthrough therapy status to its FA drug nomlabofusp and backs a potential accelerated path.
Zacks·1mo ago
<
1
2
...
>

Latest LRMR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.